Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

RSS icon
Thumbnail

Second death linked to vaping reported in Oregon

A second death, this time in Oregon, has been linked e-cigarette use after a patient was diagnosed with a severe respiratory illness.

Thumbnail

$69B CVS-Aetna deal cleared by court

U.S. District Court Judge Richard Leon has approved the $69 billion acquisition of Aetna by CVS Health, he announced in an opinion on Sept. 4.

Thumbnail

OIG audit reveals Medicare overpaid millions for prescription drugs in hospice care

Medicare Part D overpaid millions of dollars for prescription drugs that should have been covered by the Medicare Part A hospice benefit, according to a recent report from the Office of Inspector General (OIG), which conducted an audit from 2016 payments. In other words, CMS paid twice for the same drugs.

Thumbnail

CVS adds $2M to campaign to end youth vaping

CVS Health announced a $2 million contribution to an existing $50 million campaign to end e-cigarette use, known as vaping, among teenagers. The announcement comes at a time when hundreds of lung disease injuries linked to vaping have appeared in dozens of states.

Thumbnail

Purdue Pharma prepares for bankruptcy

Purdue Pharma, the maker of popular opioid OxyContin, is preparing to file for bankruptcy before the end of September if the company doesn’t reach a settlement over thousands of lawsuits against the company for its role in the opioid abuse epidemic, Reuters reported, citing people familiar with the matter.

 

Thumbnail

Humana joins Consumer Technology Association

Health insurance giant and care services provider Humana has joined the Consumer Technology Association, marking the first time a payer has joined the association.

Thumbnail

CVS aims to avoid hyperinflated drugs

More than 3,400 drugs saw price hikes in the first half of 2019, with the average increase being more than five times the rate of inflation, according to CVS Caremark.

Thumbnail

Hurricane Dorian prompts public health emergencies

HHS Secretary Alex Azar declared public health emergencies for Georgia and South Carolina on Sept. 2 in preparation for Hurricane Dorian.

Displaying 2441 - 2448 of 6652

Around the web

Cardiovascular Business
Q&A: Why are cardiovascular devices involved in so many recalls? FDA policies may be to blame

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup